Chrysophanol Attenuates Glucocorticoid‐Induced Osteoporosis by Targeting the E74‐Like Factor 5/Osteoglycin‐Regulated PI3K/AKT/mTOR Signaling Axis: An In Vitro and In Vivo Study
Abstract
Glucocorticoid‐induced osteoporosis (GIOP) is the most common form of secondary osteoporosis, characterized by severe impairment of osteoblast function and increased bone fragility. Current therapeutic options inadequately address glucocorticoid (GC)‐induced osteoblast apoptosis and suppress osteogenesis, highlighting the need for novel targeted interventions. To explore the molecular pathogenesis of GIOP and identify therapeutic targets, we performed integrated transcriptomic analysis, bioinformatics approaches, and multiple experimental validation methods. We demonstrate that dexamethasone (DEX), a prototypical GC, robustly upregulates osteoglycin (OGN) expression in both cellular and animal models. Crucially, the transcription factor ELF5 functions as a critical transcriptional repressor of OGN, counteracting DEX effects. ELF5‐mediated OGN repression is essential for maintaining pro‐survival PI3K/AKT/mTOR signaling integrity in osteoblasts. Molecular docking confirmed stable, high‐affinity binding between the natural compound chrysophanol and OGN. Functionally, chrysophanol effectively antagonized DEX‐induced OGN elevation and mitigated osteoblast apoptosis. This work is the first to define a role for the DEX‐OGN‐ELF5 axis in PI3K/AKT/mTOR signaling as critical for osteoblast survival in GIOP. Chrysophanol, as a novel natural compound targeting this OGN‐centric axis, presents a promising and potentially safer therapeutic alternative to bisphosphonates, which are…
Read the paper
Related studies
- Irisin Enhances Osteoblast DifferentiationIn Vitro
- Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo
- Interaction between Schwann Cells and Osteoblasts In Vitro
- Administration of cinnamaldehyde promotes osteogenesis in ovariectomized rats and differentiation of osteoblast in vitro
- The Effect of the Major Components of Fructus Cnidii on Osteoblasts In Vitro
- Estrogen depletion alters osteogenic differentiation and matrix production by osteoblasts in vitro
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.